Combination therapy with oncolytic viruses and immune checkpoint inhibitors in head and neck squamous cell carcinomas: an approach of complementary advantages

Squamous cell carcinomas are the most common head and neck malignancies. Significant progress has been made in standard therapeutic methods combining surgery, radiation, and chemotherapy. Nevertheless, the 5-year survival rate remains at 40–50%. Immune checkpoint inhibitors (ICIs) are a new strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hui, Li, Mengli, Yang, Chen, Wei, Wei, He, Xianglei, Cheng, Gang, Wang, Shibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814316/
https://www.ncbi.nlm.nih.gov/pubmed/36604694
http://dx.doi.org/10.1186/s12935-022-02846-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814316/
https://www.ncbi.nlm.nih.gov/pubmed/36604694
http://dx.doi.org/10.1186/s12935-022-02846-x

Ejemplares similares